129 related articles for article (PubMed ID: 22856870)
21. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
22. Primary Cutaneous T-cell Lymphoma With Aberrant CD-20 Expression.
Karimkhani C; McLaughlin C; Smith C
J Drugs Dermatol; 2015 May; 14(5):515-6. PubMed ID: 25942672
[TBL] [Abstract][Full Text] [Related]
23. Beyond clonal detection: defining the T-cell clone.
Guitart J
Arch Dermatol; 2005 Sep; 141(9):1159-60. PubMed ID: 16172316
[No Abstract] [Full Text] [Related]
24. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
25. Low BCL7A expression predicts poor prognosis in ovarian cancer.
Sun Z; Sun L; He M; Pang Y; Yang Z; Wang J
J Ovarian Res; 2019 May; 12(1):41. PubMed ID: 31077237
[TBL] [Abstract][Full Text] [Related]
26. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
28. cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.
Usener D; Schadendorf D; Koch J; Dübel S; Eichmüller S
J Invest Dermatol; 2003 Jul; 121(1):198-206. PubMed ID: 12839582
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics.
Botros N; Cerroni L; Shawwa A; Green PJ; Greer W; Pasternak S; Walsh NM
Am J Dermatopathol; 2015 Apr; 37(4):274-83. PubMed ID: 25794369
[TBL] [Abstract][Full Text] [Related]
30. High-throughput sequencing of the T-cell receptor β chain gene distinguishes 2 subgroups of cutaneous T-cell lymphoma.
Wang J; Rea B; Haun P; Emerson R; Kirsch I; Bagg A
J Am Acad Dermatol; 2019 Apr; 80(4):1148-1150.e1. PubMed ID: 30365996
[No Abstract] [Full Text] [Related]
31. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens.
Agbay RL; Torres-Cabala CA; Patel KP; Merril ED; Duvic M; Quesada A; Prieto VG; Aung PP; Loghavi S; Young KH; Hu S; Ferrufino-Schmidt MC; Tetzlaff M; Li S; Medeiros LJ; Miranda RN
Am J Surg Pathol; 2017 Apr; 41(4):431-445. PubMed ID: 28248813
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous lymphoma].
Beyeler M; Burg G; Dummer R
Hautarzt; 2004 Oct; 55(10):1005-16; quiz 1017. PubMed ID: 15349694
[TBL] [Abstract][Full Text] [Related]
34. Lymphomatoid plaquosis - a CD30+ lymphoproliferative rash exhibiting a predilection for recurrence on the same skin sites.
Lai C; Haddadeen C; Cho SY; Fityan A; Bates A; Theaker J; Healy E
Acta Derm Venereol; 2015 Jan; 95(1):104-5. PubMed ID: 24733405
[No Abstract] [Full Text] [Related]
35. PLCG1 Gene Mutations Are Uncommon in Cutaneous T-Cell Lymphomas.
Caumont C; Gros A; Boucher C; Mélard P; Prochazkova-Carlotti M; Laharanne E; Pham-Ledard A; Vergier B; Chevret E; Beylot-Barry M; Merlio JP; Cappellen D
J Invest Dermatol; 2015 Sep; 135(9):2334-2337. PubMed ID: 25910029
[No Abstract] [Full Text] [Related]
36. Early changes in gene expression of the entire pathological process in Cutaneous T-cell lymphoma.
Li Y; Wang X; Li Y; Ma R; Zhao Z; Ren J; Men J
J Cell Biochem; 2019 Oct; 120(10):17472-17480. PubMed ID: 31106473
[TBL] [Abstract][Full Text] [Related]
37. Prognosis and staging of cutaneous T-cell lymphoma.
Foss FM; Sausville EA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1011-9. PubMed ID: 8522481
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
39. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
Song X; Tian Z; Wang S; Peng Z; Feng J
Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous T-cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart?
Li S; Griffin CA; Mann RB; Borowitz MJ
Mod Pathol; 2001 Jan; 14(1):10-3. PubMed ID: 11211304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
